Clinical manifestations of familial exudative vitreoretinopathy in the first year of life
https://doi.org/10.21516/2072-0076-2021-14-3-8-13
Abstract
Familial exudative vitreoretinopathy (FEVR) is a rare hereditary retinal disease characterized by polymorphism of clinical manifestations and varied prognoses. Diagnosing FEVR is particularly difficult when it manifests itself at an early age.
Purpose: to analyze the clinical manifestations of FEVR in the first year of a child’s life.
Material and methods. 69 children with FEVR were observed at the Helmholtz National Medical Research Center of Eye Diseases from January 2012 to February 2020.
Results. 15 children (2 girls and 13 boys, 22 % of all those observed) showed ophthalmic changes in their first year. The age of the patients revealing the first clinical signs ranged from 1 week to 8 months (the median was 4 months). 4 eyes (15 %) were found to have stage I of the disease, 9 (33 %) — stage II, 4 (15 %) — stage III, 7 (26 %) — stage IV, and 3 (11 %) — stage V. Stages III to V associated with bad functional prognosis were found in half of the cases (52 %), the earliest symptoms were detected at the age of 3 weeks.
Conclusions. While FEVR is a severe and potentially progressive disease, its diagnosis during the 1st year of life is important and requires improvement. Early diagnosis is complicated by the fact that the etiological and pathogenetic aspects of the disease are underresearched, which makes it necessary to focus on studying the factors contributing to the development and progression of FEVR.
About the Authors
L. A. KatarginaRussian Federation
Dr. of Med. Sci., professor, head of the department of children’s eye pathology, deputy director
14/19, Sadovaya Chernogryazskaya, Moscow,105062, Russia
E. V. Denisova
Russian Federation
Cand. of Med. Sci., senior researcher, department of children’s eye pathology
14/19, Sadovaya Chernogryazskaya, Moscow,105062, Russia
E. A. Geraskina
Russian Federation
PhD student, department of children’s eye pathology
14/19, Sadovaya Chernogryazskaya, Moscow,105062, Russia
References
1. Criswick V., Schepens C.L. Familial exudative vitreoretinopathy. Am. J. Ophthalmol. 1969 Oct; 68 (4): 578–94. doi: 10.1016/0002-9394(69)91237-9
2. Ranchod T.M., Ho L.Y., Drenser K.A., et al. Clinical presentation of familial exudative vitreoretinopathy. Ophthalmology. 2011 Oct; 118 (10): 2070–5. doi: 10.1016/j.ophtha.2011.06.020
3. Gilmour D.F. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015; 29: 1–14. doi:10.1038/eye.2014.70
4. Avetisov S.E., Kashchenko T.P., Shamshinova A.M., eds. Visual functions and their correction in children. Moscow: Meditsina; 2005 (In Russian).
5. Tang M., Ding X., Li J., et al. Novel mutations in FZD4 and phenotype-genotype correlation in Chinese patients with familial exudative vitreoretinopathy. Mol. Vis. 2016; 22: 917–32.
6. Xia F., Lyu J., Fei P., et al. Diagnosis of complicated FEVR preoperatively and intra/post-operatively: characteristics and risk factors for diagnostic timing. BMC Ophthalmol. 2019; 19: 126. doi:10.1186/s12886-019-1128-8
7. Pendergast S.D., Trese M.T. Familial exudative vitreoretinopathy. Results of surgical management. Ophthalmology. 1998 Jun; 105 (6): 1015–23. doi: 10.1016/S0161-6420(98)96002-X
8. Kashani A.H., Learned D., Nudleman E., et al. High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy. Ophthalmology. 2014 Jan; 121 (1): 262–8. doi: 10.1016/j.ophtha.2013.08.010
9. Rao F.Q., Cai X.B., Cheng F.F., et al. Mutations in LRP5, FZD4, TSPAN12, NDP, ZNF408, or KIF11 genes account for 38.7 % of Chinese patients with familial exudative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2017 May 1; 58 (5): 2623–9. doi: 10.1167/iovs.16-21324
10. Salvo J., Lyubasyuk V., Xu M., et al. Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients. Invest. Ophthalmol. Vis. Sci. March 2015; 56: 1937–46. doi:https://doi.org/10.1167/iovs.14-16065
11. Benson W.E. Familial exudative vitreoretinopathy. Trans. Am. Ophthalmol. Soc. 1995; 93:473–521. PMCID: PMC1312071
12. Wang Z., Chen C., Sun L., et al. Symmetry of folds in FEVR: A genotypephenotype correlation study. Exp. Eye Res. 2019; 019 Sep; 186:107720. doi: 10.1016/j.exer.2019.107720
13. Gologorsky D., Chang J. S., Hess D. J., Berrocal A.M. Familial exudative vitreoretinopathy in a premature child. Ophthalmic Surgery, Lasers and Imaging Retina. 2013 Nov 1; 44 (6): 603–5. doi: 10.3928/23258160-20131015-04
14. Li Y., Li J., Zhang X., Peng J., Li J., Zhao P. Identification of gene mutations in atypical retinopathy of prematurity cases. Journal of ophthalmology. 2020. Article ID 4212158. https://doi.org/10.1155/2020/4212158
15. Lee J., El-Dairi M.A., Tran-Viet D., et al. Longitudinal changes in the optic nerve head and retina over time in very young children with familial exudative vitreoretinopathy. Retina. 2019 Jan; 39 (1): 98–110. doi: 10.1097/IAE.0000000000001930
16. Kartchner J.Z., Hartnett M.E. Familial exudative vitreoretinopathy presentation as persistent fetal vasculature. Am. J. Ophthalmol. Case Rep. 2017 Jun; 6: 15–7. doi: 10.1016/j.ajoc.2017.01.001
17. Toomes C., Bottomley H.M., Scott S., et al. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2004 Jul; 45 (7): 2083–90. doi: 10.1167/iovs.03-1044.
18. Boonstra F.N., van Nouhuys C.E., Schuil J., et al. Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2009 Sep; 50 (9): 4379–85. doi: 10.1167/iovs.08-3320
19. Kogoleva L.V., Katargina L.A., Denisova E.V., Belova M.V., Osipova N.A. Retinopathy of premature kids: clinical manifestations and differential diagnostics. Head and Neck. 2017; 3: 17–24 (in Russian)
Review
For citations:
Katargina L.A., Denisova E.V., Geraskina E.A. Clinical manifestations of familial exudative vitreoretinopathy in the first year of life. Russian Ophthalmological Journal. 2021;14(3):8-13. (In Russ.) https://doi.org/10.21516/2072-0076-2021-14-3-8-13